GLTO logo

GLTO
Galecto Inc

4,103
Mkt Cap
$11.17M
Volume
66,084.00
52W High
$31.70
52W Low
$2.01
PE Ratio
-0.64
GLTO Fundamentals
Price
$7.35
Prev Close
$8.43
Open
$8.26
50D MA
$5.50
Beta
1.93
Avg. Volume
2.99M
EPS (Annual)
-$18.53
P/B
1.16
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
News Placeholder
GLTO Stock Rises A Whopping 632% Pre-Market, But Retail Investors Remain Cautious
Galecto is focused on developing treatments for oncological and liver diseases.
Stocktwits·20d ago
News Placeholder
12 titres de soins de sant en mouvement lors de la session apr s-cl ture le 13/03/2024
Gagnants Le titre Molina Healthcare (NYSE:MOH) a grimp mercredi de 24,25% 503,11 dollars lors de la session after-market. L'action Evoke Pharma (NASDAQ:EVOK) a grimp de 18,54% 0,76...
Benzinga·2y ago
News Placeholder
Galecto, Inc. Expected to Post FY2023 Earnings of ($1.56) Per Share (NASDAQ:GLTO)
Galecto, Inc. (NASDAQ:GLTO Free Report) Leerink Partnrs boosted their FY2023 earnings per share (EPS) estimates for Galecto in a report released on Monday, February 5th. Leerink...
Zolmax·2y ago
News Placeholder
Is Galecto (NASDAQ:GLTO) In A Good Position To Invest In Growth?
Just because a business does not make any money, does not mean that the stock will go down. For example, although...
Simply Wall St·2y ago

Latest GLTO News

View

Advertisement|Remove ads.

Advertisement|Remove ads.